MXPA04006975A - Human deubiquitinating protease gene on chromosome 7 and its murine ortholog. - Google Patents

Human deubiquitinating protease gene on chromosome 7 and its murine ortholog.

Info

Publication number
MXPA04006975A
MXPA04006975A MXPA04006975A MXPA04006975A MXPA04006975A MX PA04006975 A MXPA04006975 A MX PA04006975A MX PA04006975 A MXPA04006975 A MX PA04006975A MX PA04006975 A MXPA04006975 A MX PA04006975A MX PA04006975 A MXPA04006975 A MX PA04006975A
Authority
MX
Mexico
Prior art keywords
chromosome
transducing
protease gene
human
mdub7
Prior art date
Application number
MXPA04006975A
Other languages
Spanish (es)
Inventor
Hahn Chang
Original Assignee
Aventis Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0218518.9A external-priority patent/GB0218518D0/en
Application filed by Aventis Pharmaceutical Inc filed Critical Aventis Pharmaceutical Inc
Publication of MXPA04006975A publication Critical patent/MXPA04006975A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Human and murine analogs of DUBs, hematopoietic-specific, cytokine-inducible deubiquitinating proteases, clustered on chromosome 7 and their respective regulatory regions are identified. The nucleotide or proteins encoded thereby may be used in assays to identify inhibitors of hDUB7 or mDUB7. The invention also includes transducing peptides comprising an NLS or transducing sequence of hDUB7 or mDUB7 linked to a cargo molecule, and methods of delivering a biologically active protein, therapeutically effective compound, antisense nucleotide, or test compound to a cell wherein a transducing peptide is added exogenously to a cell.
MXPA04006975A 2002-03-22 2003-03-21 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog. MXPA04006975A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36660102P 2002-03-22 2002-03-22
GBGB0218518.9A GB0218518D0 (en) 2002-03-22 2002-08-09 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
PCT/US2003/008590 WO2003083050A2 (en) 2002-03-22 2003-03-21 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog

Publications (1)

Publication Number Publication Date
MXPA04006975A true MXPA04006975A (en) 2004-11-10

Family

ID=28676509

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04006975A MXPA04006975A (en) 2002-03-22 2003-03-21 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog.

Country Status (8)

Country Link
EP (1) EP1495117A4 (en)
JP (1) JP2005520567A (en)
AU (1) AU2003230701C1 (en)
BR (1) BR0307759A (en)
CA (1) CA2479647A1 (en)
IL (1) IL164088A0 (en)
MX (1) MXPA04006975A (en)
WO (1) WO2003083050A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7357896A (en) * 1995-08-09 1997-03-05 Dana-Farber Cancer Institute Deubiquitinating enzymes that regulate cell growth
CA2374745A1 (en) * 1999-08-09 2001-02-15 Incyte Genomics, Inc. Proteases and protease inhibitors
AU1071901A (en) * 1999-09-29 2001-04-30 Millennium Pharmaceuticals, Inc. 23431, a novel human ubiquitin protease

Also Published As

Publication number Publication date
BR0307759A (en) 2004-12-21
WO2003083050A3 (en) 2004-02-26
IL164088A0 (en) 2005-12-18
EP1495117A4 (en) 2005-06-08
AU2003230701A1 (en) 2003-10-13
AU2003230701B2 (en) 2008-06-05
CA2479647A1 (en) 2003-10-09
AU2003230701C1 (en) 2009-08-27
WO2003083050A2 (en) 2003-10-09
EP1495117A2 (en) 2005-01-12
JP2005520567A (en) 2005-07-14

Similar Documents

Publication Publication Date Title
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
DE60235761D1 (en) ISOFORM DES VEGFS
EP1801206A4 (en) Method for producing l-arginine, l-ornithine or l-citrulline
JP2005516072A5 (en)
ATE368053T1 (en) ANTIMICROBIAL PEPTIDES
DE59903410D1 (en) HYBRID PROTEIN TO INHIBIT MAST CELL DEGRANULATION AND USE
CY1110381T1 (en) X-CONOTOXIN Peptides as Neuronal Amine Transport Inhibitors
WO2003048205A3 (en) Novel proteins with il-6 inhibiting activity
WO2001005810A3 (en) CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6?
WO2004069200A3 (en) Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases
CA2335098A1 (en) Protease susceptibility ii
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
DK1960515T3 (en) Inflammation-inhibiting peptides
MXPA04006975A (en) Human deubiquitinating protease gene on chromosome 7 and its murine ortholog.
AR039021A1 (en) HUMAN GENE OF CHROMOSOME 7 DEUBIQUITINATING PROTEASE AND ITS MURINE ORTHOLOGIST
EP0837074A3 (en) Biologically active fibronectin fragment as cancer metastasis inhibitor
DE60329115D1 (en) TUMORANT PROPERTIES AND USE THEREOF
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
ATE452903T1 (en) MODIFIED PEPTIDES AND THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
WO2003025182A1 (en) Dna for overexpression of growth hormone and utilization thereof
NZ510812A (en) Novel peptides
DE60331802D1 (en) Gene for chlorohydrin and hydroxycarboxylic acid ester asymmetric hydrolase
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
HUP0203080A2 (en) Prv-1 gene and use thereof
WO2003072724A3 (en) Human analogs of murine deubiquitinating protease genes

Legal Events

Date Code Title Description
FG Grant or registration